tiprankstipranks
InnoCare Pharma Ltd. (HK:9969)
:9969
Hong Kong Market
9969
InnoCare Pharma Ltd.
RESEARCH TOOLSreports
Want to see HK:9969 full AI Analyst Report?

InnoCare Pharma Ltd. (9969) Ratios

2 Followers

InnoCare Pharma Ltd. Ratios

HK:9969's free cash flow for Q1 2026 was ¥0.88. For the 2026 fiscal year, HK:9969's free cash flow was decreased by ¥ and operating cash flow was ¥0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.65 5.83 7.37 4.19 4.48
Quick Ratio
 5.53 5.71 7.28 4.13 4.45
Cash Ratio
 4.27 5.11 5.86 3.93 4.19
Solvency Ratio
 0.27 0.27 -0.14 -0.20 -0.31
Operating Cash Flow Ratio
 0.07 0.14 -0.34 -0.32 -0.27
Short-Term Operating Cash Flow Coverage
 0.20 0.63 -1.89 -0.54 -0.47
Net Current Asset Value
¥ 5.16B¥ 5.28B¥ 5.16B¥ 6.03B¥ 6.62B
Leverage Ratios
Debt-to-Assets Ratio
 0.17 0.15 0.14 0.14 0.12
Debt-to-Equity Ratio
 0.25 0.21 0.19 0.19 0.16
Debt-to-Capital Ratio
 0.20 0.17 0.16 0.16 0.14
Long-Term Debt-to-Capital Ratio
 0.15 0.14 0.13 <0.01 0.04
Financial Leverage Ratio
 1.41 1.40 1.40 1.39 1.36
Debt Service Coverage Ratio
 1.12 1.47 -2.04 -0.40 -0.65
Interest Coverage Ratio
 14.45 8.21 -15.56 -18.59 -45.20
Debt to Market Cap
 0.10 0.08 0.12 0.12 0.08
Interest Debt Per Share
 1.05 0.95 0.77 0.81 0.86
Net Debt to EBITDA
 -6.77 -9.83 10.68 13.31 9.21
Profitability Margins
Gross Profit Margin
90.36%87.59%86.29%82.61%77.07%
EBIT Margin
23.86%19.18%-51.66%-82.48%-140.18%
EBITDA Margin
25.81%24.20%-45.91%-69.94%-129.24%
Operating Profit Margin
23.70%19.18%-52.09%-88.17%-123.19%
Pretax Profit Margin
29.32%27.80%-44.84%-87.23%-142.90%
Net Profit Margin
28.78%27.24%-43.65%-85.47%-141.76%
Continuous Operations Profit Margin
28.84%27.31%-44.86%-87.42%-142.90%
Net Income Per EBT
98.17%97.98%97.36%97.99%99.20%
EBT Per EBIT
123.71%144.98%86.08%98.93%116.01%
Return on Assets (ROA)
6.95%5.78%-4.68%-6.36%-8.59%
Return on Equity (ROE)
10.12%8.10%-6.55%-8.83%-11.67%
Return on Capital Employed (ROCE)
6.65%4.67%-6.30%-8.32%-9.34%
Return on Invested Capital (ROIC)
6.18%4.43%-6.13%-7.16%-7.94%
Return on Tangible Assets
7.12%5.92%-4.70%-6.39%-8.63%
Earnings Yield
3.37%3.21%-4.53%-5.93%-4.98%
Efficiency Ratios
Receivables Turnover
 5.13 4.53 2.88 4.59M 3.52
Payables Turnover
 1.15 1.55 1.08 0.95 1.21
Inventory Turnover
 1.39 1.75 1.45 1.08 2.20
Fixed Asset Turnover
 3.44 2.94 0.95 0.68 0.66
Asset Turnover
 0.24 0.21 0.11 0.07 0.06
Working Capital Turnover Ratio
 0.37 0.34 0.15 0.11 0.09
Cash Conversion Cycle
 16.21 53.94 40.48 -44.93 -32.03
Days of Sales Outstanding
 71.19 80.61 126.92 <0.01 103.57
Days of Inventory Outstanding
 262.87 208.55 251.99 338.46 166.27
Days of Payables Outstanding
 317.85 235.22 338.43 383.39 301.87
Operating Cycle
 334.07 289.16 378.91 338.46 269.84
Cash Flow Ratios
Operating Cash Flow Per Share
 0.06 0.11 -0.22 -0.39 -0.38
Free Cash Flow Per Share
 0.02 0.07 -0.26 -0.54 -0.63
CapEx Per Share
 0.04 0.04 0.05 0.15 0.25
Free Cash Flow to Operating Cash Flow
 0.29 0.66 1.21 1.38 1.65
Dividend Paid and CapEx Coverage Ratio
 1.26 2.91 -0.83 -2.62 -1.51
Capital Expenditure Coverage Ratio
 1.40 2.91 -4.67 -2.64 -1.53
Operating Cash Flow Coverage Ratio
 0.06 0.12 -0.29 -0.50 -0.45
Operating Cash Flow to Sales Ratio
 0.04 0.09 -0.36 -0.91 -0.90
Free Cash Flow Yield
0.17%0.67%-4.57%-8.69%-5.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 29.62 31.11 -22.06 -16.87 -20.10
Price-to-Sales (P/S) Ratio
 7.23 8.47 9.63 14.42 28.49
Price-to-Book (P/B) Ratio
 2.91 2.52 1.45 1.49 2.35
Price-to-Free Cash Flow (P/FCF) Ratio
 602.57 148.84 -21.90 -11.50 -19.04
Price-to-Operating Cash Flow Ratio
 202.79 97.76 -26.59 -15.87 -31.51
Price-to-Earnings Growth (PEG) Ratio
 0.06 -0.13 0.74 0.44 -0.02
Price-to-Fair Value
 2.91 2.52 1.45 1.49 2.35
Enterprise Value Multiple
 21.23 25.19 -10.29 -7.31 -12.84
Enterprise Value
 13.71B 14.00B 4.77B 3.78B 10.37B
EV to EBITDA
 21.26 25.19 -10.29 -7.31 -12.84
EV to Sales
 5.49 6.10 4.72 5.11 16.59
EV to Free Cash Flow
 457.55 107.07 -10.74 -4.08 -11.09
EV to Operating Cash Flow
 130.53 70.32 -13.04 -5.62 -18.34
Tangible Book Value Per Share
 4.02 4.42 3.97 4.18 5.14
Shareholders’ Equity Per Share
 4.15 4.39 3.98 4.19 5.13
Tax and Other Ratios
Effective Tax Rate
 0.02 0.02 >-0.01 >-0.01 0.02
Revenue Per Share
 1.42 1.30 0.60 0.43 0.42
Net Income Per Share
 0.41 0.36 -0.26 -0.37 -0.60
Tax Burden
 0.98 0.98 0.97 0.98 0.99
Interest Burden
 1.23 1.45 0.87 1.06 1.02
Research & Development to Revenue
 0.38 0.37 0.81 1.02 1.02
SG&A to Revenue
 0.30 0.31 0.31 0.07 0.08
Stock-Based Compensation to Revenue
 0.01 0.00 -0.01 0.09 0.21
Income Quality
 0.15 0.32 0.81 1.04 0.63
Currency in CNY